CHARMER Highlights Newsletter

March 2022

In this first annual update, we share the background to CHARMER and our aims over the next few years. We also include highlights from our first 18 months, including:

  • Developing a hospital deprescribing ‘Core Outcome Set’ (COS), which is a list of things that people think are important to measure in a hospital deprescribing trial
  • Establishing a Primary Care Advisory Group to better understand the effects of proactive deprescribing in primary care

Read the newsletter here.

Good for you, good for us, good for everybody: a plan to reduce overprescribing to make patient care better and safer, support the NHS, and reduce carbon emissions

September 2021

A national overprescribing review acknowledges that “Overprescribing is a complex issue, involving systems and culture as well as individuals, and tackling it needs a system-wide response, with clinicians and patients both receiving more support to ensure the NHS is getting prescribing right.”

Read the full report here.